# Study Evaluating The Coadministration of Begacestat And Donepezil

> **NCT00959881** · PHASE1 · COMPLETED · sponsor: **Wyeth is now a wholly owned subsidiary of Pfizer** · enrollment: 47 (actual)

## Conditions studied

- Healthy Subjects

## Interventions

- **DRUG:** Donepezil plus placebo
- **DRUG:** Donepezil
- **DRUG:** Begacestat

## Key facts

- **NCT ID:** NCT00959881
- **Lead sponsor:** Wyeth is now a wholly owned subsidiary of Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-08
- **Primary completion:** 2009-11
- **Final completion:** 2009-11
- **Target enrollment:** 47 (ACTUAL)
- **Last updated:** 2011-04-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00959881

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00959881, "Study Evaluating The Coadministration of Begacestat And Donepezil". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT00959881. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*